Teleflex Dirección

Dirección controles de criterios 4/4

El CEO de Teleflex's es Liam Kelly , nombrado en May 2016, tiene una permanencia de 7.92 años. compensación anual total es $9.04M, compuesta por 11.7% salario y 88.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.059% de las acciones de la empresa, por valor de $5.91M. La antigüedad media del equipo directivo y de la junta directiva es de 4 años y 6.3 años, respectivamente.

Información clave

Liam Kelly

Chief Executive Officer (CEO)

US$9.0m

Compensación total

Porcentaje del salario del CEO	11.7%
Permanencia del CEO	7.9yrs
Participación del CEO	0.06%
Permanencia media de la dirección	4yrs
Promedio de permanencia en la Junta Directiva	6.3yrs

Actualizaciones recientes de la dirección

Recent updates

What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?

Apr 21

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Mar 06

Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate

Feb 19

Teleflex Incorporated (NYSE:TFX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Oct 13

Teleflex Shares Hit Hard As Growth Concerns Stack Up

Oct 13

Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$200?

Sep 27

Here's What To Make Of Teleflex's (NYSE:TFX) Decelerating Rates Of Return

Aug 07

Teleflex: Flexing Its Muscles A Bit

Jul 27

Is Teleflex (NYSE:TFX) A Risky Investment?

Jul 20

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 40% Above Its Share Price

Jul 05

Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings

Jun 22

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Jun 20

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

May 05

These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well

Apr 17

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Mar 31

At US$223, Is Teleflex Incorporated (NYSE:TFX) Worth Looking At Closely?

Mar 14

Teleflex's 2 catheter devices get FDA clearance

Feb 22

Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns

Jan 27

Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet

Jan 12

Teleflex Already Getting A Pretty Good Benefit Of The Doubt

Jan 11

An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued

Dec 28

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Dec 12

Teleflex recalls over 2.7M bacterial filters – FDA

Nov 01

Teleflex: More Constructive Following Recent Weakness, Valuations Noteworthy

Oct 25

Investors Met With Slowing Returns on Capital At Teleflex (NYSE:TFX)

Oct 17

Is Teleflex (NYSE:TFX) Using Too Much Debt?

Oct 03

Is Teleflex Incorporated (NYSE:TFX) Trading At A 44% Discount?

Sep 05

Teleflex to acquire Standard Bariatrics for $170M

Aug 22

Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching

Aug 08

Telefex: Valuations Are Stretched, Lack Of Risk Premia To Harvest

Jul 25

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

Jul 12

Teleflex' Urolift System shows positive data in five studies to treat enlarged prostate

Jul 01

Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?

Jun 27

Are Investors Undervaluing Teleflex Incorporated (NYSE:TFX) By 37%?

May 30

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Liam Kelly en comparación con los beneficios de Teleflex?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	US$9m	US$1m	US$358m
Oct 01 2023	n/a	n/a	US$405m
Jul 02 2023	n/a	n/a	US$369m
Apr 02 2023	n/a	n/a	US$363m
Dec 31 2022	US$8m	US$1m	US$363m
Sep 25 2022	n/a	n/a	US$412m
Jun 26 2022	n/a	n/a	US$510m
Mar 27 2022	n/a	n/a	US$488m
Dec 31 2021	US$9m	US$982k	US$485m
Sep 26 2021	n/a	n/a	US$434m
Jun 27 2021	n/a	n/a	US$351m
Mar 28 2021	n/a	n/a	US$280m
Dec 31 2020	US$6m	US$943k	US$336m
Sep 27 2020	n/a	n/a	US$367m
Jun 28 2020	n/a	n/a	US$479m
Mar 29 2020	n/a	n/a	US$551m
Dec 31 2019	US$7m	US$869k	US$462m
Sep 29 2019	n/a	n/a	US$442m
Jun 30 2019	n/a	n/a	US$269m
Mar 31 2019	n/a	n/a	US$183m
Dec 31 2018	US$6m	US$846k	US$196m
Sep 30 2018	n/a	n/a	US$66m
Jul 01 2018	n/a	n/a	US$89m
Apr 01 2018	n/a	n/a	US$170m
Dec 31 2017	US$3m	US$617k	US$155m

Compensación vs. Mercado: La compensación total de Liam($USD9.04M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD13.51M).

Compensación vs. Ingresos: La compensación de Liam ha sido consistente con los resultados de la empresa en el último año.

CEO

Liam Kelly (56 yo)

7.9yrs

Permanencia

US$9,039,947

Compensación

Mr. Liam J. Kelly has been Chief Executive Officer at Teleflex Incorporated since January 01, 2018 and has been its Director since May 4, 2018. He serves as Independent Director of Enovis Corporation (form...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Liam Kelly	Chairman	7.9yrs	US$9.04m	0.059% $ 5.8m
Thomas Powell	Executive VP & CFO	12.1yrs	US$3.53m	0.022% $ 2.2m
Daniel Logue	Corporate VP	3.3yrs	US$1.81m	0.021% $ 2.1m
Jay White	Corporate VP & President of Global Commercial	3.2yrs	US$2.37m	0.0070% $ 681.5k
John Deren	Corporate VP & Chief Accounting Officer	6.9yrs	sin datos	0.0042% $ 411.8k
Timothy Duffy	VP & Chief Information Officer	no data	sin datos	sin datos
Howard Cyr	Corporate VP & Chief Compliance Officer	2.4yrs	sin datos	sin datos
Cameron Hicks	Corporate Vice President of Human Resources & Communications	11yrs	US$1.34m	0.016% $ 1.6m
James Ferguson	President & GM of Surgical	no data	sin datos	sin datos
Michelle Fox	Corporate VP & Chief Medical Officer	4.3yrs	sin datos	sin datos
Matthew James	President	3.8yrs	sin datos	sin datos
Jake Newman	President of The Americas	3.2yrs	sin datos	sin datos

4.0yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de TFX se considera experimentado (4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Liam Kelly	Chairman	5.9yrs	US$9.04m	0.059% $ 5.8m
John Heinmiller	Independent Director	5.3yrs	US$308.20k	0.0060% $ 581.3k
Gretchen Frances Haggerty	Independent Director	7.6yrs	US$308.20k	0.0076% $ 740.0k
Stuart Randle	Independent Director	14.9yrs	US$324.53k	0.0092% $ 892.8k
Andrew Krakauer	Independent Director	6.3yrs	US$303.28k	0.0095% $ 924.0k
Stephen Klasko	Independent Lead Director	15.9yrs	US$350.30k	0.017% $ 1.6m
Candace Duncan	Independent Director	8.9yrs	US$313.82k	0.0086% $ 835.4k
Jaewon Ryu	Independent Director	less than a year	US$364.30k	sin datos
Neena Patil	Independent Director	2yrs	US$301.20k	0.00085% $ 82.8k

6.3yrs

Permanencia media

67yo

Promedio de edad

Junta con experiencia: La junta directiva de TFX se considera experimentada (6.3 años de antigüedad promedio).

Teleflex Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Teleflex Incorporated, Annual General Meeting, May 03, 2024

Chairman notifies of intention to sell stock

Executive VP & CFO exercised options and sold US$1.4m worth of stock

Independent Director notifies of intention to sell stock

Independent Director exercised options and sold US$161k worth of stock

Chairman exercised options and sold US$1.0m worth of stock

Recent updates

What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?

Teleflex Incorporated, Annual General Meeting, May 03, 2024

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Fourth quarter dividend of US$0.34 announced

Full year 2023 earnings: EPS misses analyst expectations

Teleflex Incorporated Announces Quarterly Dividend, Payable on March 15, 2024

Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate

Is Teleflex (NYSE:TFX) A Risky Investment?

Getting In Cheap On Teleflex Incorporated (NYSE:TFX) Might Be Difficult

Teleflex Incorporated Offers Its Titan SGS Stapler with Staple Line Reinforcement

Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?

Chairman notifies of intention to sell stock

Executive VP & CFO exercised options and sold US$1.4m worth of stock

Teleflex Incorporated Announces First Patient Enrollment in ACCESS-MANTA Registry

Teleflex Incorporated Announces A New Peer-Reviewed Study in the Nature Journal Prostate Cancer and Prostatic Diseases Confirms the Position of the UroLift System as the Gold Standard in Minimally Invasive Surgical Treatment

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Teleflex Incorporated Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt

Teleflex Incorporated (NYSE:TFX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Teleflex Shares Hit Hard As Growth Concerns Stack Up

Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million.

Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million.

Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$200?

Teleflex Incorporated Announces Extension of Arrow ErgoPack Complete System to Hemodialysis and Large Bore Central Venous Catheters

Here's What To Make Of Teleflex's (NYSE:TFX) Decelerating Rates Of Return

Upcoming dividend of US$0.34 per share at 0.6% yield

Teleflex Incorporated Updates Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Teleflex Incorporated Receives FDA Clearance for Expanded Indication for QuikClot Control+(TM) Hemostatic Device Usage in Cardiac Surgical Procedures

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB for $650 million.

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB from Östersjöstiftelsen, Endowment Arm, Praktikerinvest AB and Recipharm Venture Fund AB for $650 million.

Teleflex: Flexing Its Muscles A Bit

Is Teleflex (NYSE:TFX) A Risky Investment?

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 40% Above Its Share Price

Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Teleflex Incorporated Receives FDA Clearance for the Wattson Temporary Pacing Guidewire

Teleflex Incorporated Announces the Arrow(R) EZ-Io(R) Needle Is Now FDA Cleared for Use in an MRI Environment

Independent Director notifies of intention to sell stock

Teleflex Announces Quarterly Dividend, June 15, 2023

Teleflex Incorporated Provides Earnings Guidance for the Year 2023

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% undervalued

These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 37% Above Its Share Price

At US$223, Is Teleflex Incorporated (NYSE:TFX) Worth Looking At Closely?

Full year 2022 earnings: EPS misses analyst expectations

Teleflex's 2 catheter devices get FDA clearance

Independent Director exercised options and sold US$161k worth of stock

Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns

Chairman exercised options and sold US$1.0m worth of stock

Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet

Teleflex Already Getting A Pretty Good Benefit Of The Doubt

Chairman notifies of intention to sell stock

An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Price target decreased to US$248

Insufficient new directors

Upcoming dividend of US$0.34 per share

Teleflex Incorporated Announces Worldwide Recall of Affected Lots of Gibeck Iso-Gard Filter Products

Teleflex recalls over 2.7M bacterial filters – FDA

Price target decreased to US$248

Teleflex Incorporated Revises Earnings Guidance for the Year 2022

Third quarter 2022 earnings: EPS misses analyst expectations

Teleflex: More Constructive Following Recent Weakness, Valuations Noteworthy

Investors Met With Slowing Returns on Capital At Teleflex (NYSE:TFX)

Is Teleflex (NYSE:TFX) Using Too Much Debt?